Kingdom Capital
Kingdom Capital is a venture capital and private equity firm established in 2016, located in Chesterfield, Missouri. The firm focuses on early and growth-stage investments in mature and established companies across various sectors, including healthcare, technology, media, and real estate. It emphasizes sectors such as artificial intelligence, data science, therapeutics, medical devices, diagnostics, healthcare IT, and life science tools. Kingdom Capital aims to create a values-driven ecosystem that connects its investors with impactful investment opportunities, fostering collaboration with philanthropic partners through its Kingdom Capital Foundation. This strategic integration enhances the flow of capital into the philanthropic community, supporting both financial and social returns.
Canopy Biosciences
Series A in 2018
Canopy Biosciences is a biotechnology company specializing in research tools for gene editing, molecular biology, and personalized medicine. Founded in 2016 and headquartered in St. Louis, Missouri, the company offers a range of products and services designed to enhance scientific discovery in biomedical research. Its gene editing technology, known as TUNR, facilitates targeted modifications in the genome by inserting polyA tracks into specific coding regions, which reduces mRNA levels and subsequently suppresses protein expression. This innovative approach supports researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, advancing the fields of genetic engineering and gene expression analysis. Canopy Biosciences operates as a subsidiary of Bruker Corporation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.